Avery W. Catlin
2015
In 2015, Avery W. Catlin earned a total compensation of $1.9M as Senior Vice President and Chief Financial Officer at Celldex Therapeutics, a 56% increase compared to previous year.
Compensation breakdown
| Bonus | $130,000 |
|---|---|
| Option Awards | $1,436,359 |
| Salary | $339,457 |
| Other | $6,024 |
| Total | $1,911,840 |
Catlin received $1.4M in option awards, accounting for 75% of the total pay in 2015.
Catlin also received $130K in bonus, $339.5K in salary and $6K in other compensation.
Rankings
In 2015, Avery W. Catlin's compensation ranked 4,896th out of 13,638 executives tracked by ExecPay. In other words, Catlin earned more than 64.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,896 out of 13,638 | 64th |
Division Manufacturing | 1,806 out of 5,190 | 65th |
Major group Chemicals And Allied Products | 642 out of 1,854 | 65th |
Industry group Drugs | 510 out of 1,528 | 67th |
Industry In Vitro and In Vivo Diagnostic Substances | 17 out of 76 | 78th |
Source: SEC filing on April 28, 2017.
Catlin's colleagues
We found four more compensation records of executives who worked with Avery W. Catlin at Celldex Therapeutics in 2015.